The story of Sildenafil presents a complex case for observers in the medicinal sector. While initially a phenomenal success, generating vast sums, the intellectual property end and the subsequent flood of generic https://pharma894170.slypage.com/42327624/viagra-and-big-pharma-a-risky-bet